Alkermes
ALKS
#3093
Rank
โ‚ฌ4.18 B
Marketcap
25,35ย โ‚ฌ
Share price
0.75%
Change (1 day)
-14.85%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.51 Billion

According to Alkermes's latest financial reports the company's total liabilities are โ‚ฌ0.51 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.56 B-32.79%
2023-12-31โ‚ฌ0.84 B-1.56%
2022-12-31โ‚ฌ0.85 B6.54%
2021-12-31โ‚ฌ0.80 B12.19%
2020-12-31โ‚ฌ0.71 B11.67%
2019-12-31โ‚ฌ0.64 B12.47%
2018-12-31โ‚ฌ0.57 B15.35%
2017-12-31โ‚ฌ0.49 B0.8%
2016-12-31โ‚ฌ0.49 B-0.76%
2015-12-31โ‚ฌ0.49 B15.33%
2014-12-31โ‚ฌ0.42 B
2013-03-31โ‚ฌ0.40 B-7.2%
2012-03-31โ‚ฌ0.43 B921.08%
2011-03-31โ‚ฌ42.68 M-43.7%
2010-03-31โ‚ฌ75.81 M-23.72%
2009-03-31โ‚ฌ99.38 M-55.27%
2008-03-31โ‚ฌ0.22 B-18.83%
2007-03-31โ‚ฌ0.27 B-26.12%
2006-03-31โ‚ฌ0.37 B42.88%
2005-03-31โ‚ฌ0.25 B65.2%
2004-03-31โ‚ฌ0.15 B-34.82%
2003-03-31โ‚ฌ0.24 B-16.15%
2002-03-31โ‚ฌ0.28 B3.59%
2001-03-31โ‚ฌ0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Acorda Therapeutics
ACOR
โ‚ฌ0.22 B-55.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 13,033.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 18,947.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 19,299.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.82 B 11,389.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 5,369.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
โ‚ฌ56.71 B 10,976.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
โ‚ฌ53.71 B 10,391.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland